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Background: Evaluation of treatment programs in addiction field is a prerequisite to improve the quality 
of care. This study aimed to investigate the effectiveness of Therapeutic Community (TC) program in 
Iran. 
Methods: Individuals who had voluntarily enrolled in the TC center within a period of seven years, 
from early 2005 to late 2011, entered the study. Those who successfully completed the 14-week residential 
course were considered as ‘completers’. They were subsequently called in for urine test and interviews 
using Maudsley Addiction Profile. Urine test was conducted to determine if they were positive for heroin, 
opium, methadone, methamphetamine, bupronorphine, hashish, and tramadol.
Results:  A number of 378 individuals with mean (±SD) age of 32.5 ± 7.8 enrolled in the TC program 
during the study period, 240 individuals of whom completed the 14 weeks course (69.0%). At the end of 
the sixth year, 22% of the participants were in abstinence. Physical and mental health in abstainers proved 
to be of better conditions than those of non-abstainers (P<0.05). 
Conclusion: Considering the TC outcome in other countries, it seems that TC maintains an acceptable 
effectiveness in Iran. Prospective controlled studies are warranted to investigate the outcomes in more 
details. 
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Introduction
In 1970s Iran, a country located in Southwest Asia, was one 
of the main opium producing countries, but its cultivation was 
banned after revolution of 1979 (1). It, however, remains to be 
among the countries with the highest prevalence of opioids 
abuse (2). All substance use (except for tobacco) is illegal in 
Iran and opioids are the major substances abused in Iran (2). 
For treatment and retention of opioids-dependent individuals, 
different modalities are adopted in Iran including, among 
others, outpatient drug treatment, methadone maintenance 
treatment, narcotic anonymous, and residential therapeutic 
community (TC) treatment. Although half a century has 
passed since the establishment of TC centers in the developed 
countries (3), it has aged merely a decade in Iran. TC centers 
across Iran are supervised and financially supported by the 
Social Security Organisation. TC is a non-medical residential 
or semi-residential treatment program consisting of a number 
of phases, which commences from ‘orientation’ and leads to 
the final stage of ‘aftercare’. TC utilises a self-help approach 
and community is regarded as the unit of change rather than 
individual. A TC, practically, pursues psychological as well as 
social therapeutic objectives simultaneously. To meet this end, 
the residents are required to live a period of 3 months to 3 years 
in the therapeutic communities. As such, not only their pre-
illness performance level is reacquired (rehabilitation), but also 
a set of new behaviours, nonexistent even prior to addiction, 
are acquired (habilitation) through especially tailored programs 
(3). This program focuses on self-help, personal growth, support 
from group members, and the creation of a spiritual environment 
within the center and it is expected that, subsequent to the course, 
the lifestyle and personal identity of the clients are altered. TC 
in Iran is abstinence-oriented and maintains a 14-week course 
period, with an entrance condition of having at least 18 years of 
age and completion of the detoxification phase. Nearly thirty TC 
centers are working in Iran now. 
Assessment of substance use treatment programs is 
significantly valuable in order for the investigation of the levels 
of achievement of the program’s objectives and promoting the 
quality of medical services (4). Most studies on the outcome 
effectiveness of TC strategy have been conducted in the 
developed countries (5). A recent review study showed that 
between 9 to 56% of the clients complete the program, and that 
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many graduates attain significant recovery concerning social 
function and mental health (5). To the best of our knowledge, 
there has been no long-term study in Eastern Mediterranean 
countries investigating the different aspects of TC effectiveness 
with an adequate sample size. The present study was designed 
with an attempt of delineating the effectiveness of TC in terms 
of completion rate among its clients, and its relationship to the 
client characteristics which may highlight which types of drug 
users are best suited to therapeutic communities. Subsequent 
to the completion of the TC treatment, abstinence period was 
examined as well. Meanwhile we will compare health risk 
behaviour, physical and mental health, and social functioning 
between abstainers and non-abstainers. The validity of self-
report drug use will be checked against the results of urine test 
too.
Methods 
As an effectiveness outcome study, the present research was 
conducted in the city of Kerman, center of the largest province of 
Iran, using a pragmatic approach. The center under discussion, 
admits male clients only. Every single individual who enrolled 
in the TC center from the beginning of 2005 through to the 
end of 2011 was entered the study, therefore, the follow-up 
duration ranged between 10 months to 7 years. Considering 
the fact that most individuals suffer a relapse within the first 
three to six month of the follow up interval, the minimum 
follow up period is recommended to be designated at 6 months 
(6). Those who completed the 3 and a half-month period were 
known as ‘completers’ and those who failed were considered 
as ‘noncompleters’. The planned duration of treatment in TCs 
is 3 and a-half months, according to the national protocol. The 
demographic information including age, level of education, as well 
as substance use-related variables such as the age of drug abuse 
commence, and the number of previous withdrawal attempts 
was questioned in this phase. In the second phase, those who 
had completed the course were invited for interviews by phone, 
for which, each one received 100,000 Iranian Rials, equivalent to 
$10 USD. Those not accessible by phone were excluded (n=16). 
The primary outcome of the study was the establishment of 
abstinence. Individuals with positive urine test or self report, 
concerning drug use were considered as ‘non-abstainers’, and 
those negative in both cases were regarded as ‘clean’ subjects (4). 
Urine test was conducted to determine if they were positive for 
heroin, opium, methadone, methamphetamine, bupronorphine, 
hashish, and tramadol (Behmedico, Tehran, Iran). For self report 
examination, Maudsley Addiction Profile (MAP) questionnaire 
was adopted which questioned opioids abuse during the past 30 
days. This questionnaire is recognised as a proper instrument for 
collecting the desirable data in research and treatment services 
on opioids and alcohol dependent subjects, and investigates 
problems of patients from four aspects: opioids and alcohol use, 
health risk behaviours, physical and mental health check up, 
examination of personal and social functioning (7). The main 
use of MAP is for outcome research purposes (7).  Its application 
in addiction-related healthcare evaluation studies is approved 
by UNODC (4). Completing the questionnaire took about 15 
minutes. Reliability and validity of the Persian version of MAP 
has been approved (8).
Independent t-test or Mann-Whitney U test were adopted in 
order to compare the quantitative variables of the two groups. 
Comparison of the categorical variables of the two groups was 
carried out using Chi-Square test, and to discover the relationship 
between the variables and the completion of the TC program, 
multivariate logistic regression was employed. Survival analysis 
was, finally, used for the calculation of the proportion of subjects 
who remained abstinent.
Results
A number of 378 subjects (out of 395 individuals who were 
invited, yielding a response rate of 95.7%) entered the present 
study, with mean (±SD) age of 32.5 (±7.8), who referred to the 
TC center and enrolled in the program during a period of seven 
years. Of them, 240 subjects completed the 3 and a half-month 
period (69.0%). All the subjects were opioids dependent. Less 
than 10 percent of the subjects had college education and more 
than one third of the subjects were unemployed (Table 1).
The likelihood of TC completion increased in those with 
higher education, employed, and among those with history of 
incarceration (Table 1).
Out of the 237 subjects who completed the course, 55 cases 
showed positive urine test concerning at least one of the five 
substances of morphine, methadone, methamphetamine, 
tramadol, and hashish (Table 2). As shown in Table 2, sixteen 
respondents who self-reported no opium/heroin use in the past 
30 days tested positive, corresponding to an underreporting of 
38 percent. Based on self report and urine tests, the number of 
positives totaled 102 cases (44.9%) (Table 2).
Both physical and mental health demonstrated more desirable 
conditions in the ‘abstainer’ group (Table 3). The personal/social 
functioning variables of MAP showed no significant differences 
in the two groups (Table 3).
 At the end of the first, fourth, and sixth year, 87, 58, and 22% 
of the cases were abstinent, respectively (Figure 1).
Discussion
Currently, outcome effectiveness of TC is still a matter of 
debate (9) since some review studies concluded that evidence 
for its effectiveness is relatively poor (10), while, some other 
have approved its effectiveness (5). And as a result of unavailable 
conclusive results concerning TC outcome effectiveness (9), 
pertinent studies are highly warranted especially in developing 
countries. The present study employed a practice-based 
evidence approach in which, through data collection from 
routine practice, the authors give “a voice to practitioners and 
service users, recognising that they have first-hand knowledge 
and experience of what works, what needs to change and how it 
may change” (9). In total, 69 percent of the subjects voluntarily 
completed the TC program. In Peru, 21% of clients dropped 
out the TC program before completing the 30 days of treatment 
(11). In a recent meta-analysis it was shown that the completion 
rate ranged from 9 to 56 percent (5). One of the reasons to high 
success rate seems to be the shortness of the program duration, 
as, in traditional therapeutic communities, only around 15 to 
25 percent of the participants completed the program, with the 
majority of dropouts in the first three months (9). In a study on 
140 subjects in Tehran in a three-year period (2003 to 2005), 38% 
of the participants completed the program (12). The duration 
of the mentioned program was six months. In another study 
in Australia on 191 subjects, 34% successfully completed the 
treatment program, and the majority of completers were males, 
however, most client characteristics (such as age and level of 
education) showed no relationships with treatment completion 
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Yes (n=227) No (n=151)
Age (yrs)  
   ≤25 33(14.5) 29(19.2) 62(16.4) Ref  -- --
   26-45 170(74.9) 118(78.2) 288(76.2) 0.80 0.40-1.60 0.53
   ≥46     24(10.6) 4(2.6) 28(7.4) 3.64 0.95-13.96 0.06
Education                    
   Illiterate/Primary school        29(12.8) 29(19.2) 58(15.3) Ref  -- --
   Incomplete secondary 94(41.4) 55(36.4) 149(39.4) 1.57 0.77-3.23 0.21
   Complete secondary     79(34.8) 55(36.4) 134(35.5) 1.33 0.64-2.74 0.44
   College 25(11.0) 12(8) 37(9.8) 3.12 1.16-8.41 0.02
Marital status                                                                                   
  Single 90(39.6) 91(60.3) 181(47.9) Ref  -- --
  Married 111(48.9) 42(27.8) 153(40.5) 1.83 1.05-2.74 0.03
  Separated/Divorced                                           26(11.5) 18(11.9) 44(11.6) 1.19 0.54-2.62 0.68
Job   
   
  Unemployed        53(23.3) 83(55.0) 136(36.0) Ref  -- --
  Part time 73(32.2) 47(31.1) 120(31.7) 2.35 1.35-4.08 <0.01
  Full time 101(44.5) 21(13.9) 122(32.3) 6.92 3.67-13.04 <0.001
Age at onset of drug use                        
  ≤ 18 97(42.7) 54(35.8) 151(39.9) Ref  -- --
  > 18 130(57.3) 97(64.2) 227(60.1) 0.61 0.36-1.04 0.07
No. of detoxification attempts
  ≤ 2 48(21.1) 47(31.1) 95(25.1) Ref  -- --
  3-5 66(29.1) 44(29.1) 110(29.1) 1.39 0.73-2.65 0.31
  ≥ 6 113(49.8) 60(40) 173(45.8) 1.34 0.73-2.44 0.34
IV drug user                               
  No 183(80.6) 117(77.5) 300(79.4) Ref  -- --
  Yes 44(19.4) 34(22.5) 78(20.6) 0.64 0.35-1.19 0.16
Previously imprisoned
          
  No 145(63.9) 125(82.8) 270(71.4) Ref  -- --
  Yes 82(36.1) 26(17.2) 108(28.6) 3.13 1.73-5.65 <0.001
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(13). As for  the  present study, the probability of TC program 
completion was almost three times higher in participants 
with academic education or history of incarceration. A nearly 
significant association was seen between old age and probability 
of TC completion (Table 1), which was in line with other studies 
(5). This higher success rate may be due to a stronger internal 
motivation to change (3). It has been observed that the criminal 
justice system pressure increases the probability of retention in 
the treatment (3). Furthermore, higher treatment success in the 
employed participants may be rooted in the pressure by their 
employers for becoming clean as a pre-requisite to be reinstated 
or gaining higher social support. 
The point to be considered when comparing the completion 
rate of the present study with that of other studies, especially 
those conducted in the United States is that the main substance 
abused in the mentioned studies was cocaine (5), while no case 
of cocaine use was included in the present study. It has been 
shown that heroin and opium users portray a more probable 
treatment completion compared to users of other substances (5).
In the assessment of TC graduation results, abstinence was 
considered as the primary outcome, measured via a subjective 
(self report) and an objective (urine test) measure. With 
simultaneous consideration of the two criteria, the relapse 
rate was 78% in the follow up period. Moreover, the results of 
urinalysis failed to confirm the validity of self report, as was the 
case for opium and heroin, in which 26 individuals reported use 
based on self report, while, according to urinalysis, 42 individuals 
had had abused these substances. So it can be concluded that 
we could not rely on self reports to diagnose relapse after 
TC completion.  A Spanish study concluded that self report 
maintains the required validity (14). Concerning TC outcome 
assessment, a number of studies have sufficed to completion rate 
measurement (13,15), some have relied on self report (13,15), 
and some other, have considered relatively short periods (about 
one to two years) for relapse rate measurement (16,17). The 
advantage of the present study is a relatively longer follow up 
period and also using urine test. One year subsequent to TC 
completion in this study, 87% of the subjects were abstinent. In 
a study on Israeli heroin addicts, half the participants were clean 
after 15 months (16). And at the end of the follow up period, 22% 
of the participants were abstinent. A recent systematic review 
showed that in studies in which participants were followed 
during a six-month to six-year period, 21 to 100 percent of the 
participants suffered relapse (5). Furthermore, in a recent study 
in Iran, it was concluded that approximately half the subjects 
who were on naltrexone maintenance after detoxification, 
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Table 2. Use of different substances by 237 subjects who completed 
the TC course according to self report and urine test
Substance Self report (%) Urine test (%)
Alcohol 41(18.1) Not tested
Opium + Heroin 12+14(11.5) 42(18.5)
Methadone (legal + illegal) 10+2(5.3) 12(5.3)
Methamphetamine (Shisheh) 11(4.8) 15(6.6)




Naas 21(9.3) Not tested Figure 1. Survival analysis of proportion of individuals who remained 
abstinent
Table 3. Domains of the Maudsley Addiction (MAP) among Therapeutic Community completers (mean±SE; n=227)
Domain Abstainers Non-abstainers P 
Health risk behavior
Injecting shared needles (episodes) 0 0 --
Unprotected sex (episodes) 0.10±0.03 0.18±0.04 0.08
Health symptoms  
Physical symptoms (score) 4.0±0.4 5.7±0.5 <0.01
Psychological symptoms (score) 4.0±0.4 6.9±0.7 <0.001
Personal / Social Functioning
Wife conflict (days) 5.6±1.9 8.0±2.2 0.08
Family conflict (days) 5.5±1.2 6.5±1.3 0.27
Friends conflict (days) 4.2±2.4 8.0±2.4 0.21
Paid work (days) 24.7±0.8 24.7±0.9 0.98
Crime (days) 0.12±0.07 0.05±0.03 0.67
Total 55 172 --
discontinued this relapse prevention plan six months later (18) 
which indicates that the TC program promises a more desirable 
outcome than pharmacological interventions in similar cultural 
conditions.
The present study showed that mental and physical health in 
the abstainer group benefitted a better status compared to those 
of the participants who suffered relapse. However, personal/
social functioning showed no difference in the two groups. The 
majority of mental and physical health improvement studies 
report reduced criminal behaviour in TC completers (3).
As for the limitations of the study, it is preferable for the 
examination of changes in mental and physical health and 
social functioning of the participants, that a pretreatment 
assessment be conducted as well. In the assessment of factors 
pertinent to completion rate, it is recommended that treatment 
characteristics such as client satisfaction be also measured.
Compared to studies conducted in other countries, it can 
be concluded that TC outcome effectiveness, concerning both 
successful completion rate and abstinence rate after leaving the 
program, was acceptable in general. This study revealed a better 
physical and mental health for abstainers comparing to non-ab-
stainers. Another implication of this study is that practitioners 
may not rely on self-report of drug use in TC setting. 
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